Statement Of Cash Flows [Abstract]

Onward Medical N.V. - Filing #5877475

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
902,000 EUR
611,000 EUR
Adjustments for decrease (increase) in trade and other receivables
1,857,000 EUR
491,000 EUR
Adjustments for increase (decrease) in trade and other payables
2,313,000 EUR
1,654,000 EUR
Adjustments for increase (decrease) in employee benefit liabilities
126,000 EUR
76,000 EUR
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
898,000 EUR
726,000 EUR
Income taxes paid, classified as operating activities
167,000 EUR
106,000 EUR
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
5,741,000 EUR
EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.